Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indocyanine green to assess vascularity of ileal conduit anastomosis during pelvic exenteration
2022-002536-32Phase 2Active
- Sponsor
- Policlinico Gemelli
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indocyanine green in endometrial cancer (EC) and gynecological cancer, sponsored by Policlinico Gemelli. Primary endpoint: Benign uretero-enteric stricture rate. Started Feb 2023; status: active.
02
Drugs
indocyanine green
03
Conditions
endometrial cancer (EC)gynecological cancer
Beyond the preview
Go deeper on 2022-002536-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002536-32.